Oral bioavailability of peptides is notoriously poor
These cells transport oxygen throughout your body, including to your brain and muscles
BPC-157 Dosing for Tendon Repair Common Protocols Conservative approach (8-week cycle): Dose: 250-500mcg per day Route: Subcutaneous injection Frequency: Daily Duration: 8-12 weeks Break: 4 weeks between cycles Aggressive approach (ongoing): Dose: 500mcg daily for 6 weeks Then: 250mcg 2-3x weekly maintenance Route: Subcutaneous or intranasal Duration: Continuous until injury resolved Localized injection (advanced): Direct injection into injured tendon (medical supervision required) Dose: 250-500mcg Frequency: 1-2x weekly Duration: 4-8 weeks Results: May be superior, but requires qualified practitioner Administration Routes Subcutaneous (most common): 250-500mcg in 0.5mL water, injected daily Painless, stable delivery Consistent blood levels Intranasal: 250mcg sprayed into nostrils daily Non-invasive, good absorption Less evidence but growing anecdotal support Oral: Limited effectiveness (degraded by stomach acid) Not recommended for serious injury recovery Real-World Results: Athlete Case Studies Case 1: Chronic Patellar Tendinopathy (Runner) Situation : 3 years of patellar tendon pain, limiting running to 3 miles max Protocol : BPC-157: 500mcg daily for 8 weeks Eccentric loading exercises 3x weekly Return to training protocol structured over 12 weeks Result : After 4 months, pain-free running at pre-injury distances
NNMT Inhibition Increases Intracellular Concentrations of NAD+ and SAM in Differentiated Adipocytes
Ethics declarations Ethics approval and consent to participate The study protocol was approved by the ethics committee of Guilan University of Medical Sciences (IR.GUMS.REC.1400.197) in accordance with the World Medical Associations code of ethics (Declaration of Helsinki, revised in Brazil 2013), and registered at an ICMJE and WHO recognized registry of clinical trials (www.irct.ir) at 28/08/2021 (registration number: IRCT20200920048782N1)
